Top Key Companies for POC Infectious Diseases Market: Humor Diagnostica, Trinity Biotech, Grifols/ Novartis Diagnostics, Meridian Bioscience, Nanogen/ Elitech, Ortho-Clinical Diagnostics/ Johnson & Johnson, Orasure Technologies, SeraCare, Thermo Fisher Scientific, Alere, Siemens Healthcare, Qiagen, Roche Diagnostics, Fujirebio/ Innogenetics, Hologic/ Gen-Probe.
Global POC Infectious Diseases Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global POC Infectious Diseases Market Overview And Scope:
The Global POC Infectious Diseases Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of POC Infectious Diseases utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global POC Infectious Diseases Market Segmentation
By Type, POC Infectious Diseases market has been segmented into:
HIV
Hepatitis B Virus
Pneumonia/Streptococcus Associated lnfections
Respiratory Syncytial Virus(RSV)
lnfluenza
Clostridium Difficile Infections (CDI)
Hepatitis C Virus
Methicillin-Resistant Staphylococcus Aureus(MRSA)
Tuberculosis(TB)
Others
By Application, POC Infectious Diseases market has been segmented into:
Hospital Bedside
Physician's Office Lab
Urgent Care & Retail Clinics
Home& Self-testing
Nursing Home
Others
Regional Analysis of POC Infectious Diseases Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of POC Infectious Diseases Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The POC Infectious Diseases market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the POC Infectious Diseases market.
Top Key Companies Covered in POC Infectious Diseases market are:
Humor Diagnostica
Trinity Biotech
Grifols/ Novartis Diagnostics
Meridian Bioscience
Nanogen/ Elitech
Ortho-Clinical Diagnostics/ Johnson & Johnson
Orasure Technologies
SeraCare
Thermo Fisher Scientific
Alere
Siemens Healthcare
Qiagen
Roche Diagnostics
Fujirebio/ Innogenetics
Hologic/ Gen-Probe
Key Questions answered in the POC Infectious Diseases Market Report:
1. What is the expected POC Infectious Diseases Market size during the forecast period, 2026-2035?
2. Which region is the largest market for the POC Infectious Diseases Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the POC Infectious Diseases Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the POC Infectious Diseases Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key POC Infectious Diseases companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the POC Infectious Diseases Markets?
7. How is the funding and investment landscape in the POC Infectious Diseases Market?
8. Which are the leading consortiums and associations in the POC Infectious Diseases Market, and what is their role in the market?
Research Methodology for POC Infectious Diseases Market Report:
The report presents a detailed assessment of the POC Infectious Diseases Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: POC Infectious Diseases Market by Type
5.1 POC Infectious Diseases Market Overview Snapshot and Growth Engine
5.2 POC Infectious Diseases Market Overview
5.3 HIV
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 HIV: Geographic Segmentation
5.4 Hepatitis B Virus
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hepatitis B Virus: Geographic Segmentation
5.5 Pneumonia/Streptococcus Associated lnfections
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Pneumonia/Streptococcus Associated lnfections: Geographic Segmentation
5.6 Respiratory Syncytial Virus(RSV)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Respiratory Syncytial Virus(RSV): Geographic Segmentation
5.7 lnfluenza
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 lnfluenza: Geographic Segmentation
5.8 Clostridium Difficile Infections (CDI)
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Clostridium Difficile Infections (CDI): Geographic Segmentation
5.9 Hepatitis C Virus
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Hepatitis C Virus: Geographic Segmentation
5.10 Methicillin-Resistant Staphylococcus Aureus(MRSA)
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size (2026-2035F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Methicillin-Resistant Staphylococcus Aureus(MRSA): Geographic Segmentation
5.11 Tuberculosis(TB)
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size (2026-2035F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Tuberculosis(TB): Geographic Segmentation
5.12 Others
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size (2026-2035F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Others: Geographic Segmentation
Chapter 6: POC Infectious Diseases Market by Application
6.1 POC Infectious Diseases Market Overview Snapshot and Growth Engine
6.2 POC Infectious Diseases Market Overview
6.3 Hospital Bedside
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Bedside: Geographic Segmentation
6.4 Physician's Office Lab
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Physician's Office Lab: Geographic Segmentation
6.5 Urgent Care & Retail Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Urgent Care & Retail Clinics: Geographic Segmentation
6.6 Home& Self-testing
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Home& Self-testing: Geographic Segmentation
6.7 Nursing Home
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Nursing Home: Geographic Segmentation
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2026-2035F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 POC Infectious Diseases Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 POC Infectious Diseases Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 POC Infectious Diseases Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 HUMOR DIAGNOSTICA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 TRINITY BIOTECH
7.4 GRIFOLS/ NOVARTIS DIAGNOSTICS
7.5 MERIDIAN BIOSCIENCE
7.6 NANOGEN/ ELITECH
7.7 ORTHO-CLINICAL DIAGNOSTICS/ JOHNSON & JOHNSON
7.8 ORASURE TECHNOLOGIES
7.9 SERACARE
7.10 THERMO FISHER SCIENTIFIC
7.11 ALERE
7.12 SIEMENS HEALTHCARE
7.13 QIAGEN
7.14 ROCHE DIAGNOSTICS
7.15 FUJIREBIO/ INNOGENETICS
7.16 HOLOGIC/ GEN-PROBE
Chapter 8: Global POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 HIV
8.2.2 Hepatitis B Virus
8.2.3 Pneumonia/Streptococcus Associated lnfections
8.2.4 Respiratory Syncytial Virus(RSV)
8.2.5 lnfluenza
8.2.6 Clostridium Difficile Infections (CDI)
8.2.7 Hepatitis C Virus
8.2.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
8.2.9 Tuberculosis(TB)
8.2.10 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital Bedside
8.3.2 Physician's Office Lab
8.3.3 Urgent Care & Retail Clinics
8.3.4 Home& Self-testing
8.3.5 Nursing Home
8.3.6 Others
Chapter 9: North America POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 HIV
9.4.2 Hepatitis B Virus
9.4.3 Pneumonia/Streptococcus Associated lnfections
9.4.4 Respiratory Syncytial Virus(RSV)
9.4.5 lnfluenza
9.4.6 Clostridium Difficile Infections (CDI)
9.4.7 Hepatitis C Virus
9.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
9.4.9 Tuberculosis(TB)
9.4.10 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital Bedside
9.5.2 Physician's Office Lab
9.5.3 Urgent Care & Retail Clinics
9.5.4 Home& Self-testing
9.5.5 Nursing Home
9.5.6 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 HIV
10.4.2 Hepatitis B Virus
10.4.3 Pneumonia/Streptococcus Associated lnfections
10.4.4 Respiratory Syncytial Virus(RSV)
10.4.5 lnfluenza
10.4.6 Clostridium Difficile Infections (CDI)
10.4.7 Hepatitis C Virus
10.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
10.4.9 Tuberculosis(TB)
10.4.10 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital Bedside
10.5.2 Physician's Office Lab
10.5.3 Urgent Care & Retail Clinics
10.5.4 Home& Self-testing
10.5.5 Nursing Home
10.5.6 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 HIV
11.4.2 Hepatitis B Virus
11.4.3 Pneumonia/Streptococcus Associated lnfections
11.4.4 Respiratory Syncytial Virus(RSV)
11.4.5 lnfluenza
11.4.6 Clostridium Difficile Infections (CDI)
11.4.7 Hepatitis C Virus
11.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
11.4.9 Tuberculosis(TB)
11.4.10 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital Bedside
11.5.2 Physician's Office Lab
11.5.3 Urgent Care & Retail Clinics
11.5.4 Home& Self-testing
11.5.5 Nursing Home
11.5.6 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 HIV
12.4.2 Hepatitis B Virus
12.4.3 Pneumonia/Streptococcus Associated lnfections
12.4.4 Respiratory Syncytial Virus(RSV)
12.4.5 lnfluenza
12.4.6 Clostridium Difficile Infections (CDI)
12.4.7 Hepatitis C Virus
12.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
12.4.9 Tuberculosis(TB)
12.4.10 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital Bedside
12.5.2 Physician's Office Lab
12.5.3 Urgent Care & Retail Clinics
12.5.4 Home& Self-testing
12.5.5 Nursing Home
12.5.6 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 HIV
13.4.2 Hepatitis B Virus
13.4.3 Pneumonia/Streptococcus Associated lnfections
13.4.4 Respiratory Syncytial Virus(RSV)
13.4.5 lnfluenza
13.4.6 Clostridium Difficile Infections (CDI)
13.4.7 Hepatitis C Virus
13.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
13.4.9 Tuberculosis(TB)
13.4.10 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital Bedside
13.5.2 Physician's Office Lab
13.5.3 Urgent Care & Retail Clinics
13.5.4 Home& Self-testing
13.5.5 Nursing Home
13.5.6 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America POC Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 HIV
14.4.2 Hepatitis B Virus
14.4.3 Pneumonia/Streptococcus Associated lnfections
14.4.4 Respiratory Syncytial Virus(RSV)
14.4.5 lnfluenza
14.4.6 Clostridium Difficile Infections (CDI)
14.4.7 Hepatitis C Virus
14.4.8 Methicillin-Resistant Staphylococcus Aureus(MRSA)
14.4.9 Tuberculosis(TB)
14.4.10 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital Bedside
14.5.2 Physician's Office Lab
14.5.3 Urgent Care & Retail Clinics
14.5.4 Home& Self-testing
14.5.5 Nursing Home
14.5.6 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
POC Infectious Diseases Scope:
|
Report Data
|
POC Infectious Diseases Market
|
|
POC Infectious Diseases Market Size in 2025
|
USD XX million
|
|
POC Infectious Diseases CAGR 2025 - 2032
|
XX%
|
|
POC Infectious Diseases Base Year
|
2024
|
|
POC Infectious Diseases Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Humor Diagnostica, Trinity Biotech, Grifols/ Novartis Diagnostics, Meridian Bioscience, Nanogen/ Elitech, Ortho-Clinical Diagnostics/ Johnson & Johnson, Orasure Technologies, SeraCare, Thermo Fisher Scientific, Alere, Siemens Healthcare, Qiagen, Roche Diagnostics, Fujirebio/ Innogenetics, Hologic/ Gen-Probe.
|
|
Key Segments
|
By Type
HIV Hepatitis B Virus Pneumonia/Streptococcus Associated lnfections Respiratory Syncytial Virus(RSV) lnfluenza Clostridium Difficile Infections (CDI) Hepatitis C Virus Methicillin-Resistant Staphylococcus Aureus(MRSA) Tuberculosis(TB) Others
By Applications
Hospital Bedside Physician's Office Lab Urgent Care & Retail Clinics Home& Self-testing Nursing Home Others
|